Bionano Genomics, Inc.
BNGO
$1.12
-$0.04-3.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.93% | 9.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.93% | 9.42% | |||
| Cost of Revenue | 13.89% | 22.76% | |||
| Gross Profit | 0.86% | -3.08% | |||
| SG&A Expenses | -3.95% | 8.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.66% | 9.44% | |||
| Operating Income | 0.02% | -9.46% | |||
| Income Before Tax | 6.96% | -23.98% | |||
| Income Tax Expenses | 150.00% | 40.00% | |||
| Earnings from Continuing Operations | 6.70% | -24.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.70% | -24.00% | |||
| EBIT | 0.02% | -9.46% | |||
| EBITDA | -3.94% | -13.82% | |||
| EPS Basic | 51.62% | 20.06% | |||
| Normalized Basic EPS | 51.75% | 20.08% | |||
| EPS Diluted | 51.62% | 20.06% | |||
| Normalized Diluted EPS | 51.75% | 20.08% | |||
| Average Basic Shares Outstanding | 92.83% | 55.13% | |||
| Average Diluted Shares Outstanding | 92.83% | 55.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||